Recently, we identified a subset of breast cancer cell lines and primary breast cancers that exhibit aberrant DNA hypermethylation that results in concurrent epigenetic silencing of multiple methylation-sensitive genes secondary to DNA methyltransferase enzyme hyperactivity associated with overexpression of DNMT3b (12). This evidence concerns the gene DNMT3B and breast cancer.